Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma

Urology

Volumn 51, Issue 5, 1998, Pages 693-696

  Nativ, Ofer ^a   Sabo, Edmond ^a   Reiss, Ari ^a   Wald, Moshe ^a   Madjar, Shahar ^a   Moskovitz, Boaz ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; KIDNEY CARCINOMA; MALE; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL NUCLEUS; COLORING AGENTS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; NEPHRECTOMY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; VON WILLEBRAND FACTOR;

EID: 0031799337     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00019-3     Document Type: Article

References (25)

1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol. 101:1969;297-301.
2. Rafla S. Renal cell carcinoma natural history and results of treatment . Cancer. 25:1970;26-40.
3. Kloppel G, Knofel WT, Baisch H, Otto U. Prognosis of renal cell carcinoma related to nuclear grade, DNA DNA content and Robson stage. Eur Urol. 12:1986;426-431.
4. Delahunt B, Nacey JN. Renal cell carcinoma. II. Histologic indicators of prognosis. Pathology. 19:1987;258-263.
5. Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S, Morales P. Renal cell carcinoma survival and prognostic factor . Urology. 27:1996;291-301.
6. Takashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placental growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54:1994;4233-4237.
7. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 3:1992;65-71.
8. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 147:1995;9-19.
9. O'Brien TS, Harria AL. Angiogensis in urological malignancy. Br J Urol. 76:1995;675-682.
10. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 6:1982;655-663.
11. Beahrs OH, Henson DE, Hutter RVP, Myers MH. American Joint Committee on Cancer Manual for Staging of Cancer. 4th ed. 1992;201-202 JB Lippincott, Philadelphia.
12. Nativ O, Sabo E, Raviv G, Medalia O, Moskovitz B, Goldwasser B. The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma. Cancer. 76:1995;1440-1444.
13. Pinkus GS, Ethridge CL, O'Connor EM. Are keratin proteins a better tumor marker then epithelial membrane antigen? A comparative immunohistological study of various paraffin embedded neoplasms using monoclonal and polyclonal methods . Am J Clin Pathol. 85:1986;269-277.
14. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
15. O'Reilly M, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin a novel angiogenesis inhibitor that mediates the supression of metastases by a Lewis lung carcinoma . Cell. 79:1994;315-328.
16. Zhang HT, Craft P, Scott P, Ziche M, Weich HA, Harris AL, Bicknell R. Enhancement of tumor growth and vascular density by transfection of vascular endothelial growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst. 87:1995;213-219.
17. Yoshino S, Kato M, Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol. 2:1995;156-160.
18. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma lack of prognostic significance . Urology. 46:1995;27-30.
19. Kohler HH, Barth PJ, Siebel A, Gerharz EW, Bittinger A. Quantitative assessment of vascular surface density in renal cell carcinoma. Br J Urol. 77:1996;650-654.
20. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst. 86:1994;356-361.
21. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama SI, Fukui K, Ishizawa M, Yamada Y. Angiogenic factor (letter). Nature. 356:1992;668.
22. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
23. Peters W, Teixeira M, Intaglietta M, Gross JF. Microcirculatory studies in a rat mammary carcinoma. I. Transparent chamber method, development of microvascularture, and pressures in tumor vessels. J Natl Cancer Inst. 65:1980;631-642.
24. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmonn RL, Waldman FM, Carrol PR. Tumor angiogenesis correlates with lympy node metastases in invasive bladder cancer. J Urol. 154:1995;69-71.
25. Silberman MA, Partin AW, Veltri RW, Epstein JI. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 andenocarcinoma of the prostate. Cancer. 79:1997;772-779.